edoxudin and Colonic Neoplasms

edoxudin has been researched along with Colonic Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bocsi, J; Budai, B; Katona, C; Kralovánszky, J; Oláh, J; Otvös, L; Timár, F1
Jeney, A; Kopper, L; Lapis, K; Magyarosy, E; Otvös, L; Szabolcs, A1
Erdélyi-Tóth, V; Jeney, A; Katona, C; Kovács, P; Kralovánszky, J; Noordhuis, P; Otvös, L; Pandi, E; Peters, GJ; Van der Wilt, CL1

Other Studies

3 other study(ies) available for edoxudin and Colonic Neoplasms

ArticleYear
[Potentiation of 5-fluorouracil efficacy. Molecular mechanisms playing a role in the cytotoxic action of 5-fluorouracil and 5-ethyl-2'-deoxyuridine (EUdR) combination].
    Magyar onkologia, 2004, Volume: 48, Issue:3

    Topics: Antimetabolites, Antineoplastic; Apoptosis; Blotting, Western; Cell Line, Tumor; Colonic Neoplasms; Deoxyuridine; DNA Fragmentation; Drug Synergism; Electrophoresis, Polyacrylamide Gel; Flow Cytometry; Fluorouracil; Humans; Microscopy, Fluorescence; Proliferating Cell Nuclear Antigen; Time Factors; Tumor Suppressor Protein p53

2004
Potentiation of the antitumor action of 5-fluorouracil with 5-ethyl-2'-deoxyuridine in human colorectal tumor xenografts.
    Oncology, 1984, Volume: 41, Issue:3

    Topics: Adenocarcinoma, Mucinous; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Colonic Neoplasms; Deoxyuridine; Drug Synergism; Fluorouracil; Humans; Mice; Mice, Inbred CBA; Neoplasm Transplantation; Rectal Neoplasms; RNA, Neoplasm; Transplantation, Heterologous

1984
5-ethyl-2'-deoxyuridine, a modulator of both antitumour action and pharmacokinetics of 5-fluorouracil.
    Journal of cancer research and clinical oncology, 1999, Volume: 125, Issue:12

    Topics: Animals; Antimetabolites, Antineoplastic; Area Under Curve; Colonic Neoplasms; Deoxyuridine; Dose-Response Relationship, Drug; Drug Synergism; Fluorodeoxyuridylate; Fluorouracil; Male; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Time Factors; Treatment Outcome; Uracil; Uridine

1999